Literature DB >> 27723559

Deuteron induced Tb-155 production, a theranostic isotope for SPECT imaging and auger therapy.

C Duchemin1, A Guertin2, F Haddad3, N Michel3, V Métivier2.   

Abstract

Several terbium isotopes are suited for diagnosis or therapy in nuclear medicine. Tb-155 is of interest for SPECT imaging and/or Auger therapy. High radionuclide purity is mandatory for many applications in medicine. The quantification of the activity of the produced contaminants is therefore as important as that of the radionuclide of interest. The experiments performed at the ARRONAX cyclotron (Nantes, France), using the deuteron beam delivered up to 34MeV, provide an additional measurement of the excitation function of the Gd-nat(d,x)Tb-155 reaction and of the produced terbium and gadolinium contaminants. In this study, we investigate the achievable yield for each radionuclide produced in natural gadolinium as a function of the deuteron energy. Other reactions are discussed in order to define the production route that could provide Tb-155 with a high yield and a high radionuclide purity. This article aims to improve data for the Gd-nat(d,x) reaction and to optimize the irradiation conditions required to produce Tb-155.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deuteron beam; Gadolinium target; Stacked-foil technique; TALYS 1.6; Terbium-155

Mesh:

Substances:

Year:  2016        PMID: 27723559     DOI: 10.1016/j.apradiso.2016.09.030

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations.

Authors:  Charlotte Duchemin; Thomas E Cocolios; Kristof Dockx; Gregory J Farooq-Smith; Olaf Felden; Roberto Formento-Cavaier; Ralf Gebel; Ulli Köster; Bernd Neumaier; Bernhard Scholten; Ingo Spahn; Stefan Spellerberg; Maria E Stamati; Simon Stegemann; Hannelore Verhoeven
Journal:  Front Med (Lausanne)       Date:  2021-05-12

2.  Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN.

Authors:  Ben Webster; Peter Ivanov; Ben Russell; Sean Collins; Thierry Stora; Joao Pedro Ramos; Ulli Köster; Andrew Paul Robinson; David Read
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.